OCTREOTIDE ACETATE
| Brand name | OCTREOTIDE ACETATE |
|---|---|
| Active ingredient | OCTREOTIDE ACETATE |
| Strength | EQ 20MG BASE/VIAL |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Modality | Small molecule |
| FDA approval | December 2025 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| CGT | July 2026 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.